Of note, our previous study found that the PPH treatment could suppress glucose production via inhibiting gluconeogenic signaling in the hepatic AML-12 cells (11), results from the present study further provided in vivo demonstration of this finding. This evidence concerns the gene ENO1 and acute myeloid leukemia.